RSV is a contagious virus that can lead to hospitalization and other complications, especially in older adults. In the United States, an RSV vaccine has been approved for adults 60 years of age and older. However, more research is needed before it can be approved for use in other countries.
The clinical trial will help us further evaluate the safety and immune response generated by the RSV vaccine in adults 60 years of age or older. The results of this clinical trial may support the vaccine’s approval outside of the United States.
Joining a clinical trial is an important and personal decision. Thank you for considering participation.
This clinical trial is enrolling people who:
• Are at least 60 years of age
• Are generally healthy with no major changes in recent medical history
• Have not received a previous RSV vaccine or plan to receive one (other than the study vaccine) during the study
• Do not have a history of severe side effects from or allergic reactions to any vaccine
There are other requirements that the team will discuss with you.
The RSV vaccine and all clinical trial procedures will be provided at no cost. You will also be compensated for completing clinical trial activities.
Please email studies@westcoastresearch.com or call at 925-413-1451.
West Coast Research
7033 Village Parkway, Suite 211
Dublin, CA 94568
westcoastresearch.com